Further studies are still necessary to obtain a better understanding of IL-21’s role in SLE, the expression throughout the disease evolution, the association of IL-21 levels with clinical variables in SLE in longitudinal studies, and the action of its polymorphism to the risk of SLE. This evidence concerns the gene IL21 and systemic lupus erythematosus.